Drug profile · INN
lopinavir + ritonavir
KALETRA
lopinavir + ritonavir (KALETRA) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — lopinavir + ritonavir
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
lopinavir + ritonavir (KALETRA) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is lopinavir + ritonavir?
lopinavir + ritonavir (KALETRA) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.
What is the brand name for lopinavir + ritonavir?
KALETRA is a marketed brand name for lopinavir + ritonavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.